At Freenome, we’re connecting people
with next-generation cancer screening and
diagnostic tests through the power
of artificial intelligence.


Using blood work
to detect cancer

Freenome's blood tests look beyond mutations to detect the
body's own early-warning signs for cancer, including
real-time changes in gene expression, immune activity, and
cancer-associated proteins.

Decoding hidden patterns

By using artificial intelligence (AI) to recognize
disease-associated patterns among billions of circulating, 
cell-free (cf) biomarkers, Freenome is developing simple, 
accurate, and noninvasive blood tests for early-cancer
screening and treatment selection.


AI Genomics

Cancer Biology

Analyzing fragments of
DNA, RNA and other
biomarkers circulating in
blood plasma.

Learn more

Artificial intelligence

Decoding the billions of
complex patterns associated
with the body's response to
specific tumor types.

Learn More

Detection & Treatment

Arming physicians with
powerful blood tests to find
cancer earlier and fight it
more effectively.

Learn More